| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/11/2011 | WO2011095534A1 sGC STIMULATORS OR sGC ACTIVATORS ALONE AND IN COMBINATION WITH PDE5 INHBITORS FOR THE TREATMENT OF CYSTIC FIBROSIS |
| 08/11/2011 | WO2011095495A1 Compositions and methods for inhibiting expression of ikk2 genes |
| 08/11/2011 | WO2011095452A1 Aryl benzylamine compounds |
| 08/11/2011 | WO2011095434A1 Tetrahydro-pyran derivatives against neurological illnesses |
| 08/11/2011 | WO2011095389A1 Use of theobromine for lowering central blood pressure |
| 08/11/2011 | WO2011095388A1 Tolterodine bead |
| 08/11/2011 | WO2011095338A1 Novel aminoalkyl-oxazole and aminoalkyl-thiazole carboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue |
| 08/11/2011 | WO2011095196A1 Hetaryl-[1,8]naphthyridine derivatives |
| 08/11/2011 | WO2011095095A1 Medicinal composition comprising alcohol-soluble and water-insoluble licorice extract, pharmaceutical preparation, pharmaceutical application, therapeutic method, and preparative method thereof |
| 08/11/2011 | WO2011095068A1 Pharmaceutically acceptable salts of pyrrolo-nitrogenous heterocyclic derivatives, preparation method and medical use thereof |
| 08/11/2011 | WO2011095059A1 Polymorphs of dasatinib, preparation methods and pharmaceutical compositions thereof |
| 08/11/2011 | WO2011095057A1 Benzimidazole derivatives and pharmaceutical compositions and uses thereof |
| 08/11/2011 | WO2011095053A1 Quinazoline derivatives, preparation methods and uses thereof |
| 08/11/2011 | WO2011095050A1 C-glycoside derivatives containing saturated 6-member rings, preparation methods and uses thereof |
| 08/11/2011 | WO2011095049A1 Optically active 2-hydroxy tetrahydrothienopyridine derivatives, preparation method and use in manufacture of medicament thereof |
| 08/11/2011 | WO2011095045A1 Pyridinone amide derivatives, preparation methods and medical uses thereof |
| 08/11/2011 | WO2011095027A1 Pyridyl cyanoguanidine derivatives |
| 08/11/2011 | WO2011095021A1 Use of black soybean seedcoat extracts in manufacture of products for preventing and treating osteoarthritis |
| 08/11/2011 | WO2011094982A1 Solid formulation of clopidogrel bisulfate and preparation method thereof |
| 08/11/2011 | WO2011094953A1 Compounds for the treatment and prevention of influenza |
| 08/11/2011 | WO2011094890A1 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| 08/11/2011 | WO2011094823A1 Compounds for treating respiratory syncytial virus infections |
| 08/11/2011 | WO2011073995A3 Liquid vaginal spray of progesterone |
| 08/11/2011 | WO2011073788A3 Balaglitazone compositions and methods |
| 08/11/2011 | WO2011069475A3 A method of preparation of an oxidized derivative of hyaluronic acid and a method of modification thereof |
| 08/11/2011 | WO2011066352A8 An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase |
| 08/11/2011 | WO2011057262A3 Treatment of infections with tp receptor antagonists |
| 08/11/2011 | WO2011055142A3 1,4-quinones and their sulfur analogues useful as ligands of n-acetyltransferases |
| 08/11/2011 | WO2011055083A3 Multilayer pharmaceutical composition that can be dispersed in water and which contains a combination of antimalarial agents |
| 08/11/2011 | WO2011053938A8 Methods and compositions for treating cancer |
| 08/11/2011 | WO2011053144A3 Methods and compositions for dysferlin exon-skipping |
| 08/11/2011 | WO2011051521A3 Use of gambierol for treating and/or preventing neurodegenerative diseases related to tau and beta-amyloid |
| 08/11/2011 | WO2011050857A3 Compositions comprising citrus flavonoids and specific cationic surface active agents for treating infestations with head lice |
| 08/11/2011 | WO2011049659A3 Novel use and method of rapamycin to treat toxic shock |
| 08/11/2011 | WO2011048612A3 Process for preparation of propargylated aminoindans or pharmaceutically acceptable salts thereof |
| 08/11/2011 | WO2011048479A3 Compositions that include anthocyanidins and methods of use |
| 08/11/2011 | WO2011047530A8 Carotenoid derivatives, preparation method and use thereof |
| 08/11/2011 | WO2011046901A3 Broad spectrum antiviral and methods of use |
| 08/11/2011 | WO2011046757A9 Accelerating thrombus resolution through augmentation of p53 activity |
| 08/11/2011 | WO2011045774A4 Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof |
| 08/11/2011 | WO2011043809A9 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 08/11/2011 | WO2011043630A9 Composition for preventing and treating obesity diseases containing highly water-soluble 2-hydroxypropyl-β-cyclodextrin as active ingredient |
| 08/11/2011 | WO2011041462A3 Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| 08/11/2011 | WO2011041384A3 Pectin compounds, methods of using pectin compounds, and methods of controlling water solubility |
| 08/11/2011 | WO2011038385A3 Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use |
| 08/11/2011 | WO2011038159A3 Dr5 ligand drug conjugates |
| 08/11/2011 | WO2011038014A3 Composition and method for treatment of diabetes |
| 08/11/2011 | WO2011034328A3 Composition including chlorophyll a as an active ingredient for preventing and treating th2-mediated immunological diseases |
| 08/11/2011 | WO2011031849A3 Anionic lipids and lipid nanostructures and methods of producing and using same |
| 08/11/2011 | WO2011022606A3 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip |
| 08/11/2011 | WO2011022440A3 Heat shock protein binding compounds, compositions, and methods for making and using same |
| 08/11/2011 | WO2011013003A3 Intranasal granisetron and nasal applicator |
| 08/11/2011 | WO2011012322A9 Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms |
| 08/11/2011 | WO2011008823A9 Peptide-mediated non-covalent delivery of active agents across the blood brain barrier |
| 08/11/2011 | WO2011002606A8 Methods of identifying a patient population eligible for treatment with nitric oxide via inhalation |
| 08/11/2011 | WO2010146408A3 Nanoparticulate olmesartan medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them |
| 08/11/2011 | WO2010143170A3 Compounds useful for treating premature aging and in particular progeria |
| 08/11/2011 | WO2010104563A3 Highly compactable and durable direct compression excipients and excipient systems |
| 08/11/2011 | WO2010100219A3 Pharmaceutical composition containing rasagiline mesylate |
| 08/11/2011 | WO2010092260A8 Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate and polymorphs thereof |
| 08/11/2011 | WO2010091822A8 N-hydroxylated amidine-, guanidine- and/or aminohydrazone-type prodrugs for application on the skin |
| 08/11/2011 | WO2010048352A8 Methods for treating eye disorders |
| 08/11/2011 | WO2010042543A3 Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto |
| 08/11/2011 | US20110197318 Seed Treatment Agent and Method for Protecting Plant |
| 08/11/2011 | US20110197292 Delivery method |
| 08/11/2011 | US20110196415 Material for aneurysm curing |
| 08/11/2011 | US20110196383 Atherosclerotic Plaque Dissolution Composition |
| 08/11/2011 | US20110196318 Gel-based phenergan composition and method of delivery |
| 08/11/2011 | US20110196045 Estrogenic compounds, process for their production and pharmaceutical uses thereof |
| 08/11/2011 | US20110196044 Production of organic compound nanoparticles with high repetition rate ultrafast pulsed laser ablation in liquids |
| 08/11/2011 | US20110196043 Methods and compositions for administration of trpv1 agonists |
| 08/11/2011 | US20110196042 Compositions and methods for influencing satiety, lipid metabolism, and fat utilization |
| 08/11/2011 | US20110196041 Novel crystal form of calcium 3-acetylaminopropane-1-sulfonate |
| 08/11/2011 | US20110196040 Skin Penetration Enhancing Systems for Polar Drugs |
| 08/11/2011 | US20110196039 Controlled release arginine formulations |
| 08/11/2011 | US20110196038 Bipolar trans carotenoid salts and their uses |
| 08/11/2011 | US20110196037 Use of nitrated lipids for treatment of side effects of toxic medical therapies |
| 08/11/2011 | US20110196036 Use of betaine |
| 08/11/2011 | US20110196035 Temporally-Controlled Treatment of Joint Disease |
| 08/11/2011 | US20110196034 Green garlic and methods of production |
| 08/11/2011 | US20110196033 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative or 5-aminolevulinic acid as active ingredient |
| 08/11/2011 | US20110196032 Pharmaceutical Dosage Form of an Antidepressant |
| 08/11/2011 | US20110196031 Compositions and methods for treating varicose veins |
| 08/11/2011 | US20110196030 Tocotrienol esters |
| 08/11/2011 | US20110196029 Composition for treating influenza a (h1n1) virus and a preparation method therefor |
| 08/11/2011 | US20110196028 PCK ACTIVATION AS A MEANS FOR ENHANCING sAPPa SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| 08/11/2011 | US20110196027 Beta-lactones as antibacterial agents |
| 08/11/2011 | US20110196026 Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 08/11/2011 | US20110196025 Polymorphs of N-Malonyl-Bis(N'-Methyl-N'-Thiobenzoylhydrazide) |
| 08/11/2011 | US20110196024 Injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases |
| 08/11/2011 | US20110196021 High Affinity Nucleic Acid Ligands of Complement System Proteins |
| 08/11/2011 | US20110196020 Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3) |
| 08/11/2011 | US20110196019 Treatment of Cancer by Inhibition of IGFBPs and Clusterin |
| 08/11/2011 | US20110196018 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases |
| 08/11/2011 | US20110196017 Micro-rna that promotes vascular integrity and uses thereof |
| 08/11/2011 | US20110196016 Compositions and Methods for Inhibiting Expression of IKK2 Genes |
| 08/11/2011 | US20110196015 N 1-2-thiophene-2-ylethyl-n2-substituted biguanide derivate, preparation method thereof, and pharmaceutical composition containing the same as active ingredients |
| 08/11/2011 | US20110196014 Methionine analogs and methods of using same |
| 08/11/2011 | US20110196013 Animal feed composition |
| 08/11/2011 | US20110196012 Deuterated macrocyclic inhibitors of viral ns3 protease |